glp 1 and cannabinoids Molecular docking of danuglipron uncovers potential crossovers between GLP- 1R the endocannabinoid system GLP-1 drugs are revolutionizing the

Amylyx updates investors on its rare disease pipeline, including avexitides Phase 3 LUCIDITY trial, AMX0035 in Wolfram syndrome, AMX0114 in ALS, and a $317M cash position with runway into 2028 through potential avexitide approval and launch in 2027.

Once weekly

A new study is warning that the packaging of marijuana edibles is being made to look like name brand popular snacks and candies and could pose a risk to young children

As healthcare professionals, the onus lies on us to stay informed about the most effective weight management solutions, including cutting-edge treatments such as Semaglutide, Tirzepatide, and other GLP-1 receptor agonists.

This natural GLP-1 support supplement is ideal for individuals seeking